First Time Loading...
T

Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867

Watchlist Manager
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
Watchlist
Price: 10.09 CNY -0.88% Market Closed
Updated: May 5, 2024

Wall Street
Price Targets

Price Targets Summary
Tonghua Dongbao Pharmaceutical Co Ltd

Wall Street analysts forecast Tonghua Dongbao Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Tonghua Dongbao Pharmaceutical Co Ltd is 14.37 CNY with a low forecast of 11.53 CNY and a high forecast of 16.52 CNY.

Lowest
Price Target
11.53 CNY
14% Upside
Average
Price Target
14.37 CNY
42% Upside
Highest
Price Target
16.52 CNY
64% Upside
Tonghua Dongbao Pharmaceutical Co Ltd Competitors:
Price Targets
MDWD
Mediwound Ltd
56% Upside
300181
Zhejiang Jolly Pharmaceutical Co Ltd
1% Upside
CARA
Cara Therapeutics Inc
552% Upside
2552
Hua Medicine
126% Upside
VENUSREM
Venus Remedies Ltd
24% Upside
600420
Shanghai Shyndec Pharmaceutical Co Ltd
57% Upside
ASRT
Assertio Holdings Inc
197% Upside
GTII
Green Thumb Industries Inc
42% Upside

Revenue
Forecast

Revenue Estimate
Tonghua Dongbao Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Tonghua Dongbao Pharmaceutical Co Ltd's revenue is 8%. The projected CAGR for the next 3 years is 12%.

8%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Tonghua Dongbao Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Tonghua Dongbao Pharmaceutical Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 13%.

11%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Tonghua Dongbao Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Tonghua Dongbao Pharmaceutical Co Ltd's net income is 11%. The projected CAGR for the next 3 years is 11%.

11%
Past Growth
11%
Estimated Growth
Estimates Accuracy
2%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Tonghua Dongbao Pharmaceutical Co Ltd's stock price target?
Price Target
14.37 CNY

According to Wall Street analysts, the average 1-year price target for Tonghua Dongbao Pharmaceutical Co Ltd is 14.37 CNY with a low forecast of 11.53 CNY and a high forecast of 16.52 CNY.

What is Tonghua Dongbao Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Tonghua Dongbao Pharmaceutical Co Ltd's revenue is 8%. The projected CAGR for the next 3 years is 12%.

What is Tonghua Dongbao Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Tonghua Dongbao Pharmaceutical Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 13%.

What is Tonghua Dongbao Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Tonghua Dongbao Pharmaceutical Co Ltd's net income is 11%. The projected CAGR for the next 3 years is 11%.